WITNESSETH:Lease Agreement • April 16th, 1999 • United Therapeutics Corp
RECITALSEscrow Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
ESCROW AGREEMENTEscrow Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
1 STOCK PURCHASE AGREEMENT United Therapeutics Corporation 1110 Spring Street Silver Spring, MD 20910 Ladies and Gentlemen: The undersigned, _________________________________(the "Investor"), hereby confirms its agreement with you as follows: 1. This...Stock Purchase Agreement • July 14th, 2000 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
ARTICLE II REPRESENTATIONS AND WARRANTIESCommon Stock Purchase Agreement • April 16th, 1999 • United Therapeutics Corp • Delaware
1 RIGHTS AGREEMENT UNITED THERAPEUTICS CORPORATIONRights Agreement • December 18th, 2000 • United Therapeutics Corp • Pharmaceutical preparations • New York
1 EXHIBIT 10.4 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this "Agreement") is entered into as of July 15, 1996 by and between Lung Rx, Inc., a Delaware corporation having its principal offices at 1824 R Street, N.W., Washington, D.C. 20009 (the...Employment Agreement • April 16th, 1999 • United Therapeutics Corp • District of Columbia
EXECUTIVE EMPLOYMENT AGREEMENT (AS AMENDED)Employment Agreement • April 16th, 1999 • United Therapeutics Corp • Maryland
EXHIBIT 10.15 MANUFACTURING AGREEMENT AGREEMENT dated as of February 11, 1998 by and between UNITED THERAPEUTICS CORPORATION ("UNITED THERAPEUTICS"), a Delaware corporation with principal offices at 1826 R Street NW, Washington DC 20009 and Steroids,...Manufacturing Agreement • June 15th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • District of Columbia
1 EXHIBIT 10.17 UAI TECHNOLOGY, INC. OFFICE LEASEUnited Therapeutics Corp • April 16th, 1999
EXHIBIT 4.2 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 16th, 1999 • United Therapeutics Corp • Delaware
3- 4 the Company or any Subsidiary or over their respective properties is required for the execution and delivery of this Agreement or the consummation of the transactions contemplated by this Agreement, except for compliance with the Blue Sky laws,...Form of Purchase Agreement • December 30th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
RECITALSIndemnification Agreement • April 16th, 1999 • United Therapeutics Corp • Maryland
AGREEMENT AND PLAN OF MERGER among UNITED THERAPEUTICS CORPORATION, DANIEL 24043 ACQUISITION CORP. LTD.Agreement and Plan of Merger • May 1st, 2018 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of April 29, 2018, by and among United Therapeutics Corporation, a Delaware corporation (“Parent”), Daniel 24043 Acquisition Corp. Ltd., a company organized under the laws of the State of Israel and a wholly-owned Subsidiary of Parent (“Merger Sub”) and SteadyMed Ltd., a company organized under the laws of the State of Israel (the “Company”).
RECITALSAsset Purchase Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
LEASELease • April 16th, 1999 • United Therapeutics Corp • District of Columbia
1 EXHIBIT 10.2 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 15th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
EXHIBIT 10.1 AGREEMENT AND PLAN OF MERGER OCTOBER 7, 1999Agreement and Plan of Merger • November 15th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
RECITALSAsset Purchase Agreement • February 1st, 2001 • United Therapeutics Corp • Pharmaceutical preparations • Delaware
WITNESSETH:Exclusive License Agreement • April 16th, 1999 • United Therapeutics Corp • New York
CREDIT AGREEMENT dated as of September 26, 2013 by and among UNITED THERAPEUTICS CORPORATION, as Borrower, THE SUBSIDIARIES OF THE BORROWER IDENTIFIED HEREIN, as the Guarantors the Lenders referred to herein, as Lenders, and WELLS FARGO BANK, NATIONAL...Credit Agreement • September 27th, 2013 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
CREDIT AGREEMENT, dated as of September 26, 2013, by and among UNITED THERAPEUTICS CORPORATION, a Delaware corporation, as Borrower, certain Subsidiaries (as hereinafter defined) of the Borrower who are or may become party to this Agreement from time to time, as Guarantors, the lenders who are or may become party to this Agreement from time to time, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Administrative Agent for the Lenders.
EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2002 • United Therapeutics Corp • Pharmaceutical preparations • Illinois
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 22, 1999 by and between SynQuest, Inc., an Illinois corporation having its principal offices at 2225 W. Harrison, Chicago, Illinois 60612 (the “Company”) and David Walsh, Ph.D. (the “Executive”).
EXHIBIT 10.8 EXCLUSIVE LICENSE AGREEMENT THIS AGREEMENT effective as of this 3rd day of December, 1996, between LUNG RX, Inc., a corporation organized and existing under the laws of the State of Delaware, with its principal place of business at 100...Exclusive License Agreement • June 10th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • Michigan
EXHIBIT 10.14 EXCLUSIVE LICENSE AGREEMENT This Exclusive License Agreement ("Agreement") is effective as of March 15, 1999 (the "Effective Date"), by and between United Therapeutics Corporation, a Delaware corporation, having an address at 68 T.W....Exclusive License Agreement • June 10th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • April 28th, 2016 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Michael Benkowitz (the “Employee”) and United Therapeutics Corporation, a Delaware corporation (the “Company”), effective as of February 14, 2012 (the “Effective Date”).
FIRST AMENDED AND RESTATED RIGHTS AGREEMENT UNITED THERAPEUTICS CORPORATION and THE BANK OF NEW YORK Rights Agent Dated as of June 30, 2008Rights Agreement • July 3rd, 2008 • United Therapeutics Corp • Pharmaceutical preparations • New York
This First Amended and Restated Rights Agreement, dated as of June 30, 2008 is entered into between United Therapeutics Corporation, a Delaware corporation (the “Company”), and The Bank of New York, a New York banking corporation (the “Rights Agent”).
ASSET PURCHASE AGREEMENT BY AND BETWEEN ABBVIE IRELAND UNLIMITED COMPANY AND UNITED THERAPEUTICS CORPORATION August 18, 2015Asset Purchase Agreement • August 19th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of August 18, 2015 (“Effective Date”), by and between AbbVie Ireland Unlimited Company, a private unlimited company incorporated under the laws of Ireland (“Buyer”), and United Therapeutics Corporation, a Delaware corporation (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • August 3rd, 2022 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
This License and Collaboration Agreement (the “Agreement”) is entered into as of September 3, 2018 (the “Execution Date”) between MannKind Corporation, a Delaware corporation (“MannKind”), having a principal place of business at 30930 Russell Ranch Road, Suite 301, Westlake Village, California 91362, and United Therapeutics Corporation, a Delaware corporation (“United Therapeutics”), having a principal place of business at 1040 Spring Street, Silver Spring, Maryland 20910.
COMMERCIALIZATION AGREEMENTCommercialization Agreement • February 27th, 2019 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Minnesota
This Commercialization Agreement (this “Agreement”) is made as of the date last signed by the Parties (the “Effective Date”), by and between United Therapeutics Corporation, a corporation incorporated under the laws of Delaware and having a place of business at 55 T.W. Alexander Drive, Research Triangle Park, North Carolina 27709 (“UT”), and Medtronic, Inc., a corporation incorporated under the laws of the State of Minnesota and having its place of business at 8200 Coral Sea Street NE, Mounds View, Minnesota 55112 (“Medtronic”), each a “Party”, collectively the “Parties.”
AMENDMENT NO. 2 TO CREDIT AGREEMENTCredit Agreement • July 28th, 2015 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 2 TO CREDIT AGREEMENT dated as of July 24, 2015 (as amended, restated, supplemented or otherwise modified from time to time this “Amendment”), is entered into by and among UNITED THERAPEUTICS CORPORATION, a Delaware corporation, as Borrower, certain Subsidiaries of the Borrower who are or may become party to the Credit Agreement from time to time, as Guarantors, the lenders who are or may become party to the Credit Agreement from time to time, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Administrative Agent for the Lenders.
AGENCY AGREEMENT Dated as of June 28, 2004 between UNITED THERAPEUTICS CORPORATION, as the Construction Agent, and WACHOVIA DEVELOPMENT CORPORATION, as the LessorAgency Agreement • July 6th, 2004 • United Therapeutics Corp • Pharmaceutical preparations • New York
THIS AGENCY AGREEMENT, dated as of June 28, 2004 (as amended, modified, extended, supplemented, restated and/or replaced from time to time, the “Agreement”), is between WACHOVIA DEVELOPMENT CORPORATION, a North Carolina corporation (the “Lessor”) and UNITED THERAPEUTICS CORPORATION, a Delaware corporation (the “Construction Agent”).
RECITALSCooperation and Strategic Alliance Agreement • June 11th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • California
EXCLUSIVE LICENSE AGREEMENT by and between Arena Pharmaceuticals, Inc. (“Arena”) United Therapeutics Corporation (“UT”) DATED AS OF NOVEMBER 15, 2018Exclusive License Agreement • January 25th, 2019 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is made as of November 15, 2018, by and between Arena Pharmaceuticals, Inc., a Delaware corporation (“Arena”), and United Therapeutics Corporation, a Delaware corporation (“UT,” and with Arena, each a “Party” and, together, the “Parties”).
FORM OF INDEMNIFICATION AGREEMENTForm of Indemnification Agreement • October 1st, 2021 • UNITED THERAPEUTICS Corp • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”), dated as of , is made by and between UNITED THERAPEUTICS CORPORATION, a Delaware public benefit corporation (the “Company”), and (the “Indemnitee”), an “agent” (as hereinafter defined) of the Company.
EXHIBIT 10.11 EXCLUSIVE LICENSE AGREEMENT This Exclusive License Agreement ("Agreement") is effective as of September 16, 1998 (the "Effective Date"), by and between United Therapeutics Corporation, a Delaware corporation, having an address at 68 T.W....Exclusive License Agreement • June 10th, 1999 • United Therapeutics Corp • Pharmaceutical preparations • New York
